AssetMark Inc’s Novavax NVAX Stock Holding History

AssetMark Inc’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.27K	Hold	241	–	–	﹤0.01%	2932
2026 Q1	$1.96K	Hold	241	–	–	﹤0.01%	2864
2025 Q4	$1.62K	Sell	241 -1	-0.4%	-$8	﹤0.01%	2819
2025 Q3	$2.1K	Buy	+242	New	+$1.88K	﹤0.01%	2618
2016 Q1	–	Sell	-1	Closed	–	–	1343
2015 Q4	$0	Buy	+1	New	+$154	﹤0.01%	1453

Other funds holding NVAX

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

AssetMark Inc's NVAX Position: Q2 2026 in Review

AssetMark Inc held its Novavax (NVAX) position steady in Q2 2026 at 241 shares worth $2.27K. The position accounts for ﹤0.01% of the portfolio, ranked #2932.

AssetMark Inc first reported a position in NVAX in Q4 2015 and has held it in 5 quarters since. 83 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

AssetMark Inc held 241 shares of Novavax worth $2.27K as of Q2 2026.
AssetMark Inc left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2932 holding.
AssetMark Inc first reported a position in Novavax in Q4 2015 and has held it in 5 quarters since.
83 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.